Arylacetamide deacetylase-like 4, encoded by the gene Gm13177, is a protein with significant implications in cellular processes. It plays a crucial role in regulating acetylation levels, a key post-translational modification involved in the regulation of various cellular functions. Gm13177 is involved in the deacetylation of specific substrates, making it an essential player in cellular homeostasis. The function of Gm13177 is primarily associated with the removal of acetyl groups from target molecules. Acetylation, a reversible chemical modification of proteins, can affect protein stability, interactions, and cellular localization. Gm13177's role in deacetylating specific substrates allows it to finely tune these molecular modifications, thereby influencing various cellular processes.
Activation of Gm13177 involves the modulation of specific cellular pathways. Several chemical activators have been identified that can promote the functional activation of Gm13177. These activators influence cellular processes such as histone acetylation, cAMP signaling, and transcriptional regulation. For instance, some activators, like histone deacetylase inhibitors, can increase histone acetylation levels around the Gm13177 gene, resulting in enhanced gene expression and subsequent protein activation. Others, like Forskolin, directly activate Gm13177 by elevating intracellular cAMP levels, which in turn activate protein kinase A (PKA), leading to the phosphorylation and activation of the protein. Overall, Gm13177 is a vital player in cellular acetylation dynamics, and its proper activation is essential for the regulation of various cellular functions. The identified chemical activators provide valuable tools for studying the precise mechanisms by which Gm13177 influences cellular processes and contribute to our understanding of the role of acetylation in cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid promotes the activation of Gm13177 by binding to its receptor, which acts as a transcription factor to upregulate the gene's expression, resulting in protein activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol indirectly activates Gm13177 by modulating the SIRT1 pathway, leading to deacetylation of proteins that interact with Gm13177, thereby enhancing its functional activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Gm13177 through the activation of protein kinase C (PKC), which in turn phosphorylates and activates the protein, leading to its functional activation. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR indirectly activates Gm13177 by activating AMP-activated protein kinase (AMPK), which subsequently phosphorylates and activates the protein, promoting its functional activation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate acts as an indirect activator of Gm13177 by inhibiting histone deacetylases (HDACs), leading to increased histone acetylation and enhanced gene expression and activation. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone activates Gm13177 by binding to glucocorticoid receptors, which act as transcription factors, leading to the upregulation of the gene's expression and subsequent protein activation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid activates Gm13177 by inhibiting histone deacetylases (HDACs), leading to increased histone acetylation around the gene, resulting in enhanced gene expression and activation. | ||||||
Butyrolactone I | 87414-49-1 | sc-201533 sc-201533A | 200 µg 1 mg | $122.00 $514.00 | 1 | |
Butyrolactone I activates Gm13177 by modulating the cell cycle, leading to increased expression and functional activation of the gene. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
Sodium Phenylbutyrate acts as an indirect activator of Gm13177 by inhibiting histone deacetylases (HDACs), leading to increased histone acetylation and enhanced gene expression and activation. | ||||||
9-cis-Retinoic acid | 5300-03-8 | sc-205589 sc-205589B sc-205589C sc-205589D sc-205589A | 1 mg 25 mg 250 mg 500 mg 5 mg | $71.00 $424.00 $3121.00 $5722.00 $148.00 | 10 | |
9-cis-Retinoic Acid promotes the activation of Gm13177 by binding to its receptor, which acts as a transcription factor to upregulate the gene's expression, resulting in protein activation. | ||||||